Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ISRCTN16456769) titled 'Repair effects of leramistat in participants with rheumatoid arthritis' on May 1.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Single
Purpose: Treatment
Primary Sponsor: Istesso Therapeutics
Condition:
Rheumatoid arthritis
Musculoskeletal Diseases
Intervention:
The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date...
Recruitment Status: Recruiting
Phase: Phase II
Date of First Enrollment: 20/04/2026
Target Sample Size: 18 ...